gabapentin has been researched along with Pulsatile Tinnitus in 23 studies
Gabapentin: A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME.
gabapentin : A gamma-amino acid that is cyclohexane substituted at position 1 by aminomethyl and carboxymethyl groups. Used for treatment of neuropathic pain and restless legs syndrome.
Excerpt | Relevance | Reference |
---|---|---|
" The terms used were: ("tinnitus" OR "subjective tinnitus") AND ("gabapentin")." | 9.22 | Analysis of Gabapentin's Efficacy in Tinnitus Treatment: A Systematic Review. ( Bahmad, F; Tavares, MP, 2022) |
"The objective of our work is to evaluate recovery induced by gabapentin alone and in association with intradermal infiltration of lidocaine in patients affected by moderate/severe tinnitus." | 9.20 | Oral gabapentin and intradermal injection of lidocaine: is there any role in the treatment of moderate/severe tinnitus? ( Bonanno, L; Cammaroto, G; Ciodaro, F; Galletti, B; Galletti, F; Mannella, VK, 2015) |
"This prospective, placebo-controlled, double-blind clinical trial evaluated the effectiveness of gabapentin in decreasing subjective features of idiopathic subjective tinnitus in the patients." | 9.13 | Gabapentin effectiveness on the sensation of subjective idiopathic tinnitus: a pilot study. ( Azarpazhooh, M; Bakhshaee, M; Ghasemi, M; Khadivi, E; Rezaei, S; Shakeri, M; Tale, M, 2008) |
"This study evaluated the effectiveness of gabapentin in treating chronic tinnitus in two populations: participants with tinnitus with associated acoustic trauma and participants with tinnitus without associated acoustic trauma." | 9.12 | Effect of gabapentin on the sensation and impact of tinnitus. ( Bauer, CA; Brozoski, TJ, 2006) |
"To evaluate the effectiveness of gabapentin (Neurontin) improve the disease-specific quality of life in patients with moderate tinnitus." | 9.12 | Treatment of tinnitus with gabapentin: a pilot study. ( Hannley, MT; Stinnet, S; Tucci, DL; Witsell, DL, 2007) |
"To assess the therapeutic benefit of gabapentin (Neurontin) for subjective idiopathic troublesome tinnitus." | 9.12 | Relief of idiopathic subjective tinnitus: is gabapentin effective? ( Chole, RA; Finnell, J; Piccirillo, JF; Spitznagel, E; Vlahiotis, A, 2007) |
"The main aim of this study was to assess the effect of gabapentin on tinnitus via a systematic review." | 8.87 | Gabapentin for tinnitus: a systematic review. ( Aazh, H; El Refaie, A; Humphriss, R, 2011) |
"Typewriter tinnitus (TT) is a rare subtype of tinnitus but different in many ways, and it is treatable in most cases with carbamazepine." | 8.12 | [Typewriter tinnitus treated with gabapentin]. ( Sehested, PC, 2022) |
"The objective of this article is to discuss the clinically effective use of gabapentin in patients with tinnitus." | 7.71 | Gabapentin for the treatment of tinnitus: a case report. ( Zapp, JJ, 2001) |
" The terms used were: ("tinnitus" OR "subjective tinnitus") AND ("gabapentin")." | 5.22 | Analysis of Gabapentin's Efficacy in Tinnitus Treatment: A Systematic Review. ( Bahmad, F; Tavares, MP, 2022) |
"The objective of our work is to evaluate recovery induced by gabapentin alone and in association with intradermal infiltration of lidocaine in patients affected by moderate/severe tinnitus." | 5.20 | Oral gabapentin and intradermal injection of lidocaine: is there any role in the treatment of moderate/severe tinnitus? ( Bonanno, L; Cammaroto, G; Ciodaro, F; Galletti, B; Galletti, F; Mannella, VK, 2015) |
"This prospective, placebo-controlled, double-blind clinical trial evaluated the effectiveness of gabapentin in decreasing subjective features of idiopathic subjective tinnitus in the patients." | 5.13 | Gabapentin effectiveness on the sensation of subjective idiopathic tinnitus: a pilot study. ( Azarpazhooh, M; Bakhshaee, M; Ghasemi, M; Khadivi, E; Rezaei, S; Shakeri, M; Tale, M, 2008) |
"This study evaluated the effectiveness of gabapentin in treating chronic tinnitus in two populations: participants with tinnitus with associated acoustic trauma and participants with tinnitus without associated acoustic trauma." | 5.12 | Effect of gabapentin on the sensation and impact of tinnitus. ( Bauer, CA; Brozoski, TJ, 2006) |
"To evaluate the effectiveness of gabapentin (Neurontin) improve the disease-specific quality of life in patients with moderate tinnitus." | 5.12 | Treatment of tinnitus with gabapentin: a pilot study. ( Hannley, MT; Stinnet, S; Tucci, DL; Witsell, DL, 2007) |
"To assess the therapeutic benefit of gabapentin (Neurontin) for subjective idiopathic troublesome tinnitus." | 5.12 | Relief of idiopathic subjective tinnitus: is gabapentin effective? ( Chole, RA; Finnell, J; Piccirillo, JF; Spitznagel, E; Vlahiotis, A, 2007) |
"Vestibular paroxysmia is defined as paroxysmal, brief, and carbamazepine-responsive vertigo." | 4.89 | Vestibular paroxysmia associated with paroxysmal pulsatile tinnitus: a case report and review of the literature. ( Chang, TP; Hsu, YC; Wu, YC, 2013) |
"The main aim of this study was to assess the effect of gabapentin on tinnitus via a systematic review." | 4.87 | Gabapentin for tinnitus: a systematic review. ( Aazh, H; El Refaie, A; Humphriss, R, 2011) |
"Typewriter tinnitus (TT) is a rare subtype of tinnitus but different in many ways, and it is treatable in most cases with carbamazepine." | 4.12 | [Typewriter tinnitus treated with gabapentin]. ( Sehested, PC, 2022) |
" We describe two patients with brief, spontaneous, recurrent attacks of tinnitus and vertigo that responded to low dose gabapentin and we argue that this clinical presentation represents the prototypical 8th nerve vascular compression syndrome." | 3.75 | Gabapentin responsive audiovestibular paroxysmia. ( Baloh, RW; Russell, D, 2009) |
"The objective of this article is to discuss the clinically effective use of gabapentin in patients with tinnitus." | 3.71 | Gabapentin for the treatment of tinnitus: a case report. ( Zapp, JJ, 2001) |
"Tinnitus is the perception of sound or noise in the absence of an external or internal acoustic stimulation." | 2.47 | Anticonvulsants for tinnitus. ( Hoekstra, CE; Rovers, MM; Rynja, SP; van Zanten, GA, 2011) |
"Tinnitus affects approximately 50 million people in the USA alone, with 10 million being highly debilitated." | 1.37 | An in vitro model for testing drugs to treat tinnitus. ( Gopal, K; Gross, GW; Lukas, TJ; Moore, EJ; Wu, C, 2011) |
"Subjective tinnitus is a common and often debilitating disorder that is difficult to study because it is a perceptual state without an objective stimulus correlate." | 1.31 | Assessing tinnitus and prospective tinnitus therapeutics using a psychophysical animal model. ( Bauer, CA; Brozoski, TJ, 2001) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 13 (56.52) | 29.6817 |
2010's | 8 (34.78) | 24.3611 |
2020's | 2 (8.70) | 2.80 |
Authors | Studies |
---|---|
Sehested, PC | 1 |
Tavares, MP | 1 |
Bahmad, F | 1 |
Chang, TP | 1 |
Wu, YC | 1 |
Hsu, YC | 1 |
Ciodaro, F | 1 |
Mannella, VK | 1 |
Cammaroto, G | 1 |
Bonanno, L | 1 |
Galletti, F | 1 |
Galletti, B | 1 |
Bauer, CA | 4 |
Berry, J | 1 |
Brozoski, TJ | 4 |
Shulman, A | 2 |
Russell, D | 1 |
Baloh, RW | 1 |
Dehkordi, MA | 1 |
Abolbashari, S | 1 |
Taheri, R | 1 |
Einolghozati, S | 1 |
Wu, C | 1 |
Gopal, K | 1 |
Gross, GW | 1 |
Lukas, TJ | 1 |
Moore, EJ | 1 |
Hoekstra, CE | 1 |
Rynja, SP | 1 |
van Zanten, GA | 1 |
Rovers, MM | 1 |
Chen, WH | 1 |
Yin, HL | 1 |
Aazh, H | 1 |
El Refaie, A | 1 |
Humphriss, R | 1 |
Strashun, AM | 1 |
Goldstein, BA | 1 |
Kanashiro, AM | 1 |
Alexandre, PL | 1 |
Pereira, CB | 1 |
Melo, AC | 1 |
Scaff, M | 1 |
Witsell, DL | 1 |
Hannley, MT | 1 |
Stinnet, S | 1 |
Tucci, DL | 1 |
Snow, JB | 1 |
Bahmad, FM | 1 |
Venosa, AR | 1 |
Oliveira, CA | 1 |
Piccirillo, JF | 1 |
Finnell, J | 1 |
Vlahiotis, A | 1 |
Chole, RA | 1 |
Spitznagel, E | 1 |
Bakhshaee, M | 1 |
Ghasemi, M | 1 |
Azarpazhooh, M | 1 |
Khadivi, E | 1 |
Rezaei, S | 1 |
Shakeri, M | 1 |
Tale, M | 1 |
Zapp, JJ | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Treating Tinnitus Using the Neuromonics Tinnitus Treatment Program: A Randomized, Double-blind Study[NCT02829073] | 120 participants (Anticipated) | Interventional | 2016-04-30 | Recruiting | |||
Gabapentin for the Relief of Idiopathic Subjective Tinnitus[NCT00317850] | Phase 2/Phase 3 | 160 participants | Interventional | 2004-04-30 | Terminated | ||
Phase 2 Effect of Gabapentin on Idiopathic Subjective Tinnitus[NCT00555776] | Phase 2 | 70 participants (Anticipated) | Interventional | 2007-01-31 | Active, not recruiting | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
6 reviews available for gabapentin and Pulsatile Tinnitus
Article | Year |
---|---|
Analysis of Gabapentin's Efficacy in Tinnitus Treatment: A Systematic Review.
Topics: Administration, Oral; Excitatory Amino Acid Antagonists; Gabapentin; Humans; Tinnitus | 2022 |
Vestibular paroxysmia associated with paroxysmal pulsatile tinnitus: a case report and review of the literature.
Topics: Aged; Amines; Anticonvulsants; Carbamazepine; Cyclohexanecarboxylic Acids; Gabapentin; gamma-Aminobu | 2013 |
Anticonvulsants for tinnitus.
Topics: Administration, Oral; Amines; Anticonvulsants; Carbamazepine; Chronic Disease; Cyclohexanecarboxylic | 2011 |
Gabapentin for tinnitus: a systematic review.
Topics: Amines; Anticonvulsants; Cyclohexanecarboxylic Acids; Gabapentin; gamma-Aminobutyric Acid; Hearing L | 2011 |
Strategies of the Tinnitus Research Consortium.
Topics: Amines; Analgesics; Biomedical Research; Consensus; Cyclohexanecarboxylic Acids; Electric Stimulatio | 2006 |
Gabapentin.
Topics: Amines; Animals; Cyclohexanecarboxylic Acids; Excitatory Amino Acid Antagonists; Gabapentin; gamma-A | 2007 |
7 trials available for gabapentin and Pulsatile Tinnitus
Article | Year |
---|---|
Oral gabapentin and intradermal injection of lidocaine: is there any role in the treatment of moderate/severe tinnitus?
Topics: Administration, Oral; Adult; Amines; Anesthetics, Local; Anticonvulsants; Cyclohexanecarboxylic Acid | 2015 |
Efficacy of gabapentin on subjective idiopathic tinnitus: a randomized, double-blind, placebo-controlled trial.
Topics: Adult; Aged; Aged, 80 and over; Amines; Calcium Channel Blockers; Cyclohexanecarboxylic Acids; Doubl | 2011 |
Effect of gabapentin on the sensation and impact of tinnitus.
Topics: Adolescent; Adult; Aged; Amines; Audiometry; Cyclohexanecarboxylic Acids; Dose-Response Relationship | 2006 |
Treatment of tinnitus with gabapentin: a pilot study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amines; Analgesics; Auditory Threshold; Cyclohexanecarbo | 2007 |
Benzodiazepines and GABAergics in treating severe disabling tinnitus of predominantly cochlear origin.
Topics: Adult; Amines; Benzodiazepines; Clonazepam; Cochlear Diseases; Cyclohexanecarboxylic Acids; Disabili | 2006 |
Relief of idiopathic subjective tinnitus: is gabapentin effective?
Topics: Adolescent; Adult; Aged; Amines; Calcium Channel Blockers; Chi-Square Distribution; Cyclohexanecarbo | 2007 |
Gabapentin effectiveness on the sensation of subjective idiopathic tinnitus: a pilot study.
Topics: Adult; Aged; Aged, 80 and over; Amines; Cyclohexanecarboxylic Acids; Double-Blind Method; Excitatory | 2008 |
10 other studies available for gabapentin and Pulsatile Tinnitus
Article | Year |
---|---|
[Typewriter tinnitus treated with gabapentin].
Topics: Adult; Carbamazepine; Female; Gabapentin; Humans; Nerve Compression Syndromes; Tinnitus; Vertigo | 2022 |
Clinical trials supported by the Tinnitus Research Consortium: Lessons learned, the Southern Illinois University experience.
Topics: Amines; Clinical Trials as Topic; Cyclohexanecarboxylic Acids; Gabapentin; gamma-Aminobutyric Acid; | 2016 |
Gabapentin and tinnitus relief.
Topics: Amines; Anticonvulsants; Brain; Clinical Trials as Topic; Cyclohexanecarboxylic Acids; Gabapentin; g | 2008 |
Gabapentin responsive audiovestibular paroxysmia.
Topics: Aged, 80 and over; Amines; Central Nervous System Agents; Cranial Nerve Diseases; Cyclohexanecarboxy | 2009 |
An in vitro model for testing drugs to treat tinnitus.
Topics: Amines; Animals; Antioxidants; Calcium Channel Blockers; Carnitine; Convulsants; Cyclohexanecarboxyl | 2011 |
Successful amelioration of tinnitus in a stroke patient by low-dose gabapentin.
Topics: Amines; Audiometry, Pure-Tone; Basal Ganglia Hemorrhage; Cerebral Angiography; Cyclohexanecarboxylic | 2012 |
GABAA-benzodiazepine-chloride receptor-targeted therapy for tinnitus control: preliminary report.
Topics: Acetates; Adult; Aged; Aged, 80 and over; Amines; Benzodiazepines; Chloride Channels; Clonazepam; Cy | 2002 |
[Vestibular paroxysmia: clinical study and treatment of eight patients].
Topics: Aged; Amines; Anticonvulsants; Carbamazepine; Cyclohexanecarboxylic Acids; Female; Gabapentin; gamma | 2005 |
Gabapentin for the treatment of tinnitus: a case report.
Topics: Acetates; Amines; Amitriptyline; Analgesics; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; | 2001 |
Assessing tinnitus and prospective tinnitus therapeutics using a psychophysical animal model.
Topics: Acetates; Amines; Animals; Cyclohexanecarboxylic Acids; Deafness; Diagnosis, Differential; Disease M | 2001 |